# Study to Evaluate Multiple Doses in Patients With Nasal Polyposis

> **NCT02734849** · PHASE2 · COMPLETED · sponsor: **Allakos Inc.** · enrollment: 40 (actual)

## Conditions studied

- Nasal Polyposis

## Interventions

- **DRUG:** AK001 low dose
- **DRUG:** AK001 high dose
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02734849
- **Lead sponsor:** Allakos Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04
- **Primary completion:** 2018-01
- **Final completion:** 2018-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2021-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02734849

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02734849, "Study to Evaluate Multiple Doses in Patients With Nasal Polyposis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02734849. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*